A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype
NCT ID: NCT04981275
Last Updated: 2023-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
81 participants
OBSERVATIONAL
2021-06-19
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.
NCT03843736
Gut Microbiome in Patients With Polycystic Ovary Syndrome
NCT02078505
Intestinal Microbiota Survey of Polycystic Ovary Syndrome
NCT02937090
The Gut Microbiome in Women With Polycystic Ovary Syndrome
NCT03642600
Gut- and Vaginal Microbiome Composition in Association With PCOS
NCT05706922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with PCOS
Women previously diagnosed with PCOS not using hormonal therapy and without other significant health or endocrine issues
No intervention study
This observational study will only collect data, not provide any intervention to participants.
Healthy controls
Women self-identifying as generally healthy, not using hormonal therapy, and without any significant health or endocrine issues
No intervention study
This observational study will only collect data, not provide any intervention to participants.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention study
This observational study will only collect data, not provide any intervention to participants.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-40 years old
* Residing in the USA, except for exclusion states
* Have not been using hormonal therapy for at least 3 months
Exclusion Criteria
* Diagnosed with other significant health conditions or using medications that will affect hormone levels
* Residing in NY, NJ, MD, RI, ND, SD, or HI
* Pregnant or nursing
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Onegevity Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chris D'Adamo, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Maryland
Chris Mason, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland
College Park, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00089723
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.